Forendo Pharma receives EUR 4 million in funding
The Finnish drug development company Forendo Pharma has raised four million euros from Vesalius Biocapital III Partners. The funding will be used to further develop Forendo’s portfolio of women’s health solutions.
Oriola wins dose dispensing contract in Sweden
Finnish company Oriola has signed an agreement with the Stockholm County Council (SLL) to engage in dose dispensing co-operation starting in February 2019.
Biohit GastroPanel finds Korean distributer
Finnish biotechology company Biohit and Dow BioMedica have signed an agreement for the distribution of Biohit GastroPanel in Korea.
Orion and Peptonic partner up for health
Finnish Orion and Swedish Peptonic Medical have announced a tech transfer agreement for VagiVital, a product set to be launched next year.
Nexstim goes commercial with new funding
Medical technology company Nexstim is raising 1.75 million euros in equity financing via a directed issue of new shares to a UK-based fund.
FIT Biotech dives into genes with Avacta
FIT Biotech has initiated a research collaboration with UK-based Avacta Group to develop gene therapies combining the companies’ strengths.
Herantis Pharma lands Nordic Stars Award
Finnish Herantis Pharma was announced as the winner of the Nordic Stars Award at the Nordic Life Sciences Days in Malmö, Sweden.
Herantis Pharma granted a US patent
The United States Patent and Trademark Office has issued a patent titled ‘Neurotrophic factor MANF and uses thereof’ to Finnish Herantis Pharma.
Helsinki institutions team up abroad for health
The Hospital District of Helsinki and Uusimaa (HUS) and the University of Helsinki are collaborating with Pfizer and GlaxoSmithKline through new partner contracts.
FIT Biotech and InnaVirVax to fight HIV
Finnish FIT Biotech and Paris-based InnaVirVax have commenced collaboration in HIV treatment that combines their proprietary immunotherapeutic HIV vaccines.